Trial Profile
The Role of Aromatase Inhibitors in the Treatment of Infertility in Obese Male.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Male infertility
- Focus Therapeutic Use
- 20 May 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 15 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 21 Jul 2010 Planned end date changed from 1 Jun 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.